李震宇, 段亚辉, 秦雪梅, 杜冠华. 中药质量差异性研究的思考J. 药学学报, 2017,52(12): 1820-1826. doi: 10.16438/j.0513-4870.2017-0622
引用本文: 李震宇, 段亚辉, 秦雪梅, 杜冠华. 中药质量差异性研究的思考J. 药学学报, 2017,52(12): 1820-1826. doi: 10.16438/j.0513-4870.2017-0622
LI Zhen-yu, DUAN Ya-hui, QIN Xue-mei, DU Guan-hua. Study of difference in quality of traditional Chinese medicinesJ. Acta Pharmaceutica Sinica, 2017,52(12): 1820-1826. doi: 10.16438/j.0513-4870.2017-0622
Citation: LI Zhen-yu, DUAN Ya-hui, QIN Xue-mei, DU Guan-hua. Study of difference in quality of traditional Chinese medicinesJ. Acta Pharmaceutica Sinica, 2017,52(12): 1820-1826. doi: 10.16438/j.0513-4870.2017-0622

中药质量差异性研究的思考

Study of difference in quality of traditional Chinese medicines

  • 摘要: 中药是中医药防病治病最重要的物质手段,其本身的内在质量直接影响到中医临床疗效和用药安全。由于中药大多来源于植物的特殊性以及化学组成的复杂性,其化学差异是客观且必然存在的。如何阐明化学差异对生物学差异的影响规律并客观评价这种差异和建立质量标准是中药质量评价的难点所在。在中药质量标准研究中,这些对生物学差异有显著影响的化学成分应作为质量控制的指标成分。本文以本课题组近年来开展的前期工作为基础,提出了中药差异性评价的研究思路,同时对其应用前景和存在问题进行展望分析。

     

    Abstract: Traditional Chinese medicinal materials (TCMMs) are the material basis of the traditional Chinese medicines (TCM) in the treatment of disease, and the inherent quality of the TCMMs are of crucial importance for the efficacy and safety of TCM. Most of the TCMMs are originated from the plants with complex chemical compositions, and the chemical diversity is inevitable. How to clarify the relationship between the chemical identity and the biological activity is the key point for quality control of TCMMs in the establishment of the quality standards. The components with great impact on the biological activities should be used as index compounds in the quality evaluation. In this study, based on the results in our previous studies, a research idea on the evaluation of quality difference of TCMMs is proposed. Its application and existing problems are also discussed.

     

/

返回文章
返回